A ‘common drug’ has provided an ‘exciting development’ on COVID 19

about 4 years in themercury

A "common drug" has provided an exciting development which "seems like it will reduce the death toll significantly for those on a ventilator" suffering from the deadly coronavirus says the Australian Medical Association (AMA) President of Western Australia Dr Andrew Miller.

On Thursday, Health Minister Greg Hunt revealed the medical expert panel approved the use of dexamethasone in Australia as a COVID-19 treatment.

In clinical trials, the widely available steroid showed to decrease the risk of death in coronavirus patients, particularly for those requiring ventilators.

Researchers in the United Kingdom announced their success with the drug on Wednesday.

Discussing the drug, Dr Miller told Sky News "the Brits have done a really good trial and they've tested it on severely ill people in the ICU for their lung inflammation".

"It seems like it will reduce the death toll significantly for those on a ventilator ... down from 50 per cent by possibly about a third.

"That's an exciting development because we've had lots of promises but nothing that's actually gone through a trial to good effect."

Image: AP

Mentioned in this news
Share it on